Formuepleje A/S’s Globe Life GL Stock Holding History

Formuepleje A/S’s Portfolio GL Stock Details GL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-147,362	Closed	-$16.2M	–	77
2023 Q1	$16.2M	Buy	147,362 +5,708	+4%	+$670K	1.19%	22
2022 Q4	$17.1M	Buy	+141,654	New	+$16.2M	1.44%	22
2014 Q2	–	Sell	-11,520	Closed	-$604K	–	43
2014 Q1	$604K	Buy	+11,520	New	+$591K	0.07%	33

Other funds holding GL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Formuepleje A/S's GL Position: Q2 2023 in Review

Formuepleje A/S sold out of Globe Life (GL) in Q2 2023, closing a stake of 147,362 shares — an estimated $16.2M sold.

Formuepleje A/S first reported a position in GL in Q1 2014 and held it in 3 quarters. The position peaked at $17.1M in Q4 2022. 541 funds tracked by Wall St. Rank hold GL as of Q2 2023.

Formuepleje A/S reported no remaining Globe Life position as of Q2 2023 after selling out during the quarter.
Formuepleje A/S sold 147,362 Globe Life shares in Q2 2023, an estimated $16.2M.
Formuepleje A/S first reported a position in Globe Life in Q1 2014 and held it in 3 quarters.
Formuepleje A/S's Globe Life position peaked at $17.1M in Q4 2022.
541 funds tracked by Wall St. Rank held Globe Life as of Q2 2023.

Based on Formuepleje A/S's 13F filing for Q2 2023, filed 27 Aug 2026.